NFKB1 and colitis: In the present work, treatment of UC with DAPA significantly improved clinical evaluation and macroscopic scoring of colitis induced by AA and these results are consistent with previous results of a study that reported that DAPA prevented colon shortening and declined disease activity through targeting the NF-κB/AMPK/NLRP3 axis [29].